A large proportion of Medical Device Manufacturers (MDMs) receive deficiency letters from the Food and Drug Administration (FDA) requesting additional information in their 510k(s), de novo and PMA submissions. Navigating these deficiency letters can be a confusing and downright tumultuous task for MDMs. There are a number of things to consider when submitting and/or responding to the FDA. This webinar will discusses the critical pieces for achieving FDA submission approval.
Speakers
Our team of FDA analysts and cybersecurity experts provide robust and actionable cybersecurity roadmaps to ensure you meet FDA requirements. Get the Medcrypt advantage today!
Naomi Schwartz
Sr Director of Cybersecurity Quality and Safety
More resources
Research, not marketing
We are dedicated to helping advance our industry’s understanding of the challenges and opportunities we face through research. Check out our whitepapers.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg)